The content on this site is intended for healthcare professionals only
Dr Blackhall presents about new therapies in SCLC at the Future Horizons in Lung Cancer meeting.
Consolidation durvalumab after cCRT shows decreased disease progression in LS-SCLC
Laser oncosurgery - A new perspective in treating cancer
Powering equity in cancer care through digital health
Research highlights in lung cancer
Uncommon genetic aberrations NTRK, RET, NRG
Innovative treatments for solid tumours – TTFields as a therapeutic modality
Adagrasib shows durable clinical benefit in advanced KRAS-mutant NSCLC
OncoAlert Round Up for August 4th - 10th, 2023
Immunotherapy in NSCLC: Adjuvant and neoadjuvant clinical scenarios
